Cervical cancer screening uptake among women in Naivasha

Abstract

Background: About 86% of the cases of cervical cancer occur in developing countries. In Kenya, cervical cancer represents 21% of all cancers in women. With a development period as long as ten years, cervical cancer is possible to control through screening and treatment. Several projects in reproductive health have been offering cervical cancer screening using visual methods through visual inspection with acetic acid or visual inspection with Lugol’s iodine (VIA/VILI). Family planning counselling programs are a good opportunity to discuss the benefits of cervical cancer screening with gynaecological examination more easily accepted. The study looked at the outcomes in relation to screening.
Methods: A total of 384 women aged 18 – 49 years were enrolled through systematic sampling in the descriptive cross sectional study. These were clients who attended the family planning clinic in June-July 2014. Participants answered questions from semi-structured questionnaires.
Results: Participants who reported to have been screened for cervical cancer were 15.4%. Those screened during the study period were 2.3% and of these, 44.4% had positive VIA/VILI results. Age-group, residence, employment status and usual treatment centre were significant in relation to cervical cancer screening uptake.
Conclusion: The availability of screening services in clinics that clients normally attend does not translate into high proportions in cervical cancer screening uptake. However, targeted screening will result in more positive cases being reported.

Keywords: Cervical cancer screening uptake, VIA/VILI, family planning clinic, Kenya

Afr J Health Sci. 2014; 29(1):13-24